miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-22
DOI
10.1002/1878-0261.12588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
- (2019) John Inge Johnsen et al. Frontiers in Molecular Neuroscience
- MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential
- (2018) Angela Galardi et al. CURRENT MEDICINAL CHEMISTRY
- Neuroblastoma
- (2018) Akira Nakagawara et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Emerging roles of Myc in stem cell biology and novel tumor therapies
- (2018) Go J. Yoshida JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Myc in elongation and repression
- (2018) Eytan Zlotorynski NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Knockout of both miR-15/16 loci induces acute myeloid leukemia
- (2018) Francesca Lovat et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overview and recent advances in the treatment of neuroblastoma
- (2017) Sarah B. Whittle et al. Expert Review of Anticancer Therapy
- A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma
- (2017) Francesca Megiorni et al. ONCOLOGY REPORTS
- Treatment and survival of childhood neuroblastoma: Evidence from a population-based study in the United States
- (2017) Diarmuid Coughlan et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015
- (2017) Frank Berthold et al. PEDIATRIC DRUGS
- Metastatic neuroblastoma in infants: are survival rates excellent only within the stringent framework of clinical trials?
- (2016) A. Di Cataldo et al. Clinical & Translational Oncology
- Genetic discoveries and treatment advances in neuroblastoma
- (2016) Rochelle Bagatell et al. CURRENT OPINION IN PEDIATRICS
- Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
- (2016) John T. Powers et al. NATURE
- Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012
- (2016) Florencia Moreno et al. PEDIATRIC BLOOD & CANCER
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy
- (2015) Kishore B. Challagundla et al. JNCI-Journal of the National Cancer Institute
- MYCN-targeting miRNAs are predominantly downregulated during MYCN‑driven neuroblastoma tumor formation
- (2015) Anneleen Beckers et al. Oncotarget
- Genetic association of gastric cancer with miRNA clusters including the cancer-related genesMIR29, MIR25, MIR93andMIR106: Results from the EPIC-EURGAST study
- (2014) Yolanda Espinosa-Parrilla et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients
- (2014) Charles-Henry Gattolliat et al. Cancer Medicine
- Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia
- (2013) S Kasar et al. ONCOGENE
- Neuroblastoma and MYCN
- (2013) M. Huang et al. Cold Spring Harbor Perspectives in Medicine
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target inMYCN-amplified neuroblastoma
- (2012) Alexander Schramm et al. INTERNATIONAL JOURNAL OF CANCER
- Physical and Functional Interaction between Ribosomal Protein L11 and the Tumor Suppressor ARF
- (2012) Mu-Shui Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- N-myc and Noncoding RNAs in Neuroblastoma
- (2012) J. Buechner et al. MOLECULAR CANCER RESEARCH
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
- (2011) J Buechner et al. BRITISH JOURNAL OF CANCER
- A Genome-Wide Search for Promoters That Respond to Increased MYCN Reveals Both New Oncogenic and Tumor Suppressor MicroRNAs Associated with Aggressive Neuroblastoma
- (2011) J. M. Shohet et al. CANCER RESEARCH
- MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma
- (2011) Bjørn Helge Haug et al. CARCINOGENESIS
- Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
- (2011) Xiao-Xin Sun et al. EMBO JOURNAL
- Ribosomal Protein L11 Recruits miR-24/miRISC To Repress c-Myc Expression in Response to Ribosomal Stress
- (2011) K. B. Challagundla et al. MOLECULAR AND CELLULAR BIOLOGY
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
- (2010) Ulf Klein et al. CANCER CELL
- microRNA Signature and Expression of Dicer and Drosha Can Predict Prognosis and Delineate Risk Groups in Neuroblastoma
- (2010) R.-J. Lin et al. CANCER RESEARCH
- MYCN-regulated microRNAs repress estrogen receptor- (ESR1) expression and neuronal differentiation in human neuroblastoma
- (2010) J. Loven et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification
- (2009) Athanasia Spandidos et al. NUCLEIC ACIDS RESEARCH
- MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
- (2009) P Mestdagh et al. ONCOGENE
- Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival
- (2009) Isabella Bray et al. PLoS One
- N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription Factor
- (2008) R. Cotterman et al. CANCER RESEARCH
- Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells
- (2008) Xi Chen et al. CELL
- High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma
- (2008) E. Fredlund et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Blockade of MicroRNA Processing by Lin28
- (2008) S. R. Viswanathan et al. SCIENCE
- Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
- (2008) Frank Westermann et al. GENOME BIOLOGY
- MYCN regulates oncogenic MicroRNAs in neuroblastoma
- (2007) Johannes H. Schulte et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now